GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET — Stella

Home/Subfertility/

View on ClinicalTrials.gov

Recruiting

Back to Subfertility trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Department of Obstetrics and Gynaecology, Hong Kong, Hong Kong

Key details

Phase

Large-scale testing

Sponsor

The University of Hong Kong

Enrollment target

~784 participants

Started

September 2019

Primary completion

September 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 42 Years

Sex

Female only

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.